Paid Clinical Trials in Chicago, IL

Browse 244 Paid Studies Chicago Across 1160 Cities
104 Phase 3 Trial · 11131 Paid Studies Chicago Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Paid Clinical Trials in Chicago, IL

Reviewed by Michael Gill, B. Sc.

Image of Vera Site # 0139 in Huntsville, United States.

Phase-Based Progress Estimates

Atacicept Dosefor Lupus Nephritis (LN)

The objective of the study is to evaluate the effect of atacicept compared to placebo on changes to renal response in adult subjects with LN.

Vera Site # 0139 (+25 Sites)Joanne CurleyVera Therapeutics, Inc.

Image of Clinical Nutrition Research Center in Chicago, United States.

Phase-Based Progress Estimates

Low Dosefor Healthy Subjects (HS)

This study is being conducted to demonstrate short chain fatty acid (SCFA), specifically butyrate, generation in stool, blood and urine in response to oral intake of ButyraGen™.

Clinical Nutrition Research CenterClinical Nutrition Research Center, Illinois Institute of Technology

Image of Northwestern Medicine Prentice Women's Hospital in Chicago, United States.

Phase-Based Progress Estimates

Baby2Home Interventionfor Postpartum Depression

The COVID-19 pandemic has transformed healthcare delivery; arguably, the fields of obstetrics and pediatrics have experienced some of the greatest changes as they have transitioned away from their role as a medical home and into more of an urgent care model of care. Baby2Home is a digital health intervention designed to bridge the resultant gaps in obstetrics and pediatrics healthcare services for new families over the first year of life. This randomized controlled trial will evaluate whether, compared to usual care, Baby2Home 1) improves maternal, paternal, and infant health service utilization outcomes over the first year postpartum, 2) improves maternal and paternal patient reported outcomes, and 3) reduces racial/ethnic and income-based disparities in preventive health services utilization and parental patient reported outcomes.

Northwestern Medicine Prentice Women's Hospital (+1 Sites)Craig Craig, MD

Image of Research Site in Los Angeles, United States.

Phase-Based Progress Estimates

Tezepelumab Low Dosefor Eosinophilic Esophagitis

Senior-friendly

A randomized, double-blind, placebo-controlled multicenter, phase 3 study to evaluate the efficacy and safety of tezepelumab administered subcutaneously (SC) using an accessorized pre-filled syringe (APFS) versus placebo in adult and adolescent patients with eosinophilic esophagitis (EoE).

Senior-friendly

Research Site (+11 Sites)Amgen

Image of Northwestern Memorial Hospital in Chicago, United States.

Phase-Based Progress Estimates

Hypothermic Machine Perfusionfor Transplantation, Liver

To provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial

Northwestern Memorial Hospital (+1 Sites)Matthew CopithorneOrgan Recovery Systems, Inc.

Image of Northwestern Memorial Hospital in Chicago, United States.

Phase-Based Progress Estimates

Group 2 (Prevena)for Surgery

This trial looks at using a special device to help with healing after spine surgery.

Northwestern Memorial Hospital3M

Image of Therafirst Medical Centers in Fort Lauderdale, United States.

Phase-Based Progress Estimates

Bictegravirfor Human Immunodeficiency Virus Type 1 (HIV-1) Infection

This trial will look at whether switching to a new antiviral regimen of bictegravir and lenacapavir is more effective than continuing on a stable baseline regimen in people with human immunodeficiency virus who are virologically suppressed.

Therafirst Medical Centers (+35 Sites)Gilead Study DirectorGilead Sciences

Image of University of Illinois at Chicago in Chicago, United States.

Phase-Based Progress Estimates

Isatuximab And Lenalidomide Maintenancefor Multiple Myeloma

This is a phase II study where patients will undergo isatuximab and lenalidomide maintenance starting at day 90 (+/-30 days) after Autologous Stem Cell Transplant (ASCT) provided they have achieved at least Partial Response (PR).Patients may have received any number of cycles of induction therapy prior to stem cell transplant.

University of Illinois at Chicago

Image of Rare Disease Research in Atlanta, United States.

Phase-Based Progress Estimates

Tadefgrobep Alfafor Oppenheim Disease

This trial will study if adding taldefgrobep alfa to current treatments for spinal muscular atrophy (SMA) is effective and safe.

Rare Disease Research (+33 Sites)Lindsey Lair, MDBiohaven Pharmaceuticals, Inc.

Image of Accurate Clinical Management, LLC in Houston, United States.

Phase-Based Progress Estimates

S-217622for Coronavirus Disease 2019 (COVID‑19)

This trial is testing a new drug against placebo to see if it is effective in treating people with COVID-19 who are not expected to benefit from standard care.

Accurate Clinical Management, LLC (+28 Sites)Shionogi

Image of Ann & Robert H. Lurie Children's Hospital in Chicago, United States.

Phase-Based Progress Estimates

GWP42003-Pfor Seizures

The primary aim of Part A of the study to assess the efficacy and tolerability of GWP42003-P compared to placebo as an adjunctive treatment for children with Epilepsy with myoclonic-atonic seizures (EMAS) -associated seizures. Part B of this study will be conducted to evaluate the long-term safety and tolerability of GWP42003-P in participants with EMAS.

Ann & Robert H. Lurie Children's Hospital (+2 Sites)Jazz Pharmaceuticals

Image of Banner University Medical Center - Tucson in Tucson, United States.

Phase-Based Progress Estimates

Sentinel Lymph Node Biopsyfor Mouth Neoplasms

This trial compares sentinel lymph node biopsy surgery to standard neck dissection for early-stage oral cavity cancer.

Banner University Medical Center - Tucson (+63 Sites)Stephen Y Lai

Image of University of Alabama Hospital in Birmingham, United States.

Phase-Based Progress Estimates

Therapeutic Hypothermiafor Anoxia-Ischemia, Brain

This trial is testing if longer periods of induced hypothermia are better for patients' neurological outcomes after cardiac arrest, in order to identify the optimal duration of induced hypothermia.

University of Alabama Hospital (+66 Sites)Robert Silbergleit

Image of Emory University School of Medicine in Atlanta, United States.

Phase-Based Progress Estimates

ST-920for Fabry Disease

This trial is testing a new treatment for Fabry disease using a virus to deliver a working copy of the gene for alpha-Gal A. The goal is to see if it's safe and tolerable in humans, and if it can provide long-term production of alpha-Gal A.

Emory University School of Medicine (+11 Sites)Medical MonitorSangamo Therapeutics

Image of City of Hope in Duarte, United States.

Phase-Based Progress Estimates

Afamitresgene Autoleucel (previously ADP-A2M4)for Synovial Sarcoma

This trial is studying a new treatment for synovial sarcoma and MRCLS.

City of Hope (+18 Sites)Deijka Aruajo, MDAdaptimmune

Image of Mayo Clinic in Scottsdale, United States.

Phase-Based Progress Estimates

Zoledronic Acid (ZA)for Multiple System Atrophy

FDA Approved Drug

This trial is testing whether a single infusion of zoledronic acid can help prevent fractures in people with Parkinson's disease or parkinsonism. A total of 3500 participants will be enrolled in the United States.

FDA Approved Drug

Mayo Clinic (+54 Sites)Steve Cummings, MD

Image of University of Alabama at Birmingham in Birmingham, United States.

Phase-Based Progress Estimates

XEN1101for Gelastic Epilepsy

Waitlist Available

This trial will test if XEN1101 is an effective and safe treatment for focal epilepsy in adults. The trial will be double-blind, meaning neither the patients nor the researchers will know who is receiving the real treatment or the placebo. There will also be an optional open-label extension, meaning that at the end of the trial, patients who wish to can receive the real treatment.

Waitlist Available

University of Alabama at Birmingham (+66 Sites)Study DirectorNCGS, Inc.

Image of Investigational Site Number 8400036 in Birmingham, United States.

Phase-Based Progress Estimates

Hepatitis B Vaccinefor Meningococcal Infections

FDA Approved Drug

This trial is testing whether a new vaccine is non-inferior to the current standard vaccine for infants and toddlers. It is also looking at the antibody response to the new vaccine and comparing it to the current standard.

FDA Approved Drug

Investigational Site Number 8400036 (+97 Sites)Clinical Sciences & OperationsSanofi Pasteur, a Sanofi Company

Image of David Geffen School of Medicine at UCLA in Los Angeles, United States.

Phase-Based Progress Estimates

SGT-001for Muscular Dystrophies

Waitlist Available

This trial is testing a new drug for Duchenne muscular dystrophy in children and adolescents. The trial will last for approximately 5 years, and subjects will receive a single infusion of the drug.

Waitlist Available

David Geffen School of Medicine at UCLA (+3 Sites)Roxana Donisa Dreghici, MDSolid Biosciences Inc.

Image of UC San Diego Moores Cancer Center in La Jolla, United States.

Phase-Based Progress Estimates

Pharmacological Studyfor Lymphoma, AIDS Related

FDA Approved Drug

This trial is studying the side effects and best dose of ibrutinib when given with other cancer treatments to patients with HIV-positive stage II-IV diffuse large B-cell lymphomas.

FDA Approved Drug

UC San Diego Moores Cancer Center (+15 Sites)Ida C Wong-Sefidan

Image of University of Massachusetts Medical SChool in Worcester, United States.

Phase-Based Progress Estimates

OA Care Planfor Osteoarthritis, Hip

Waitlist Available

This trial will develop a web-based system to help patients with knee and hip osteoarthritis make informed decisions about treatment options, in order to improve the quality of care for this condition.

Waitlist Available

University of Massachusetts Medical SChool (+1 Sites)Patricia D Franklin, MD MBA MPH

Image of Rush University Medical Center in Chicago, United States.

Phase-Based Progress Estimates

Bone Marrow Aspirate Concentratefor Arthrosis

This trial will compare the outcomes of patients who receive BMAC after meniscectomy to those who don't, in terms of symptoms, physical examination, MRI, radiographs, and synovial fluid analysis. The hypothesis is that BMAC will improve outcomes.

Rush University Medical CenterBrian J Cole, MD, MBA

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Laboratory Biomarker Analysisfor Breast

FDA Approved Drug

This trial is testing two different chemotherapy combinations to treat triple negative breast cancer to see which is more effective.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Vicente Valero

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Docetaxelfor Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7

FDA Approved Drug

This trial is testing how well radiation therapy works in combination with different drugs after surgery to treat patients with high-risk stage III-IV head and neck cancer.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Paul M Harari

Image of Preferred Primary Care Physicians in Uniontown, United States.

Phase-Based Progress Estimates

PF-07081532 20 Mg T2DMfor Diabetes Mellitus

The purpose of this study is to find out if PF-07081532 ("the active study drug"), is safe and helps treat people with obesity without diabetes to lose weight, and people with diabetes to keep their blood sugar in good control. Individuals diagnosed with diabetes that are on metformin or individuals with obesity without diabetes will be included in the study. Those participating in the diabetes part of the study, will receive either active study drug, placebo, or an approved treatment called Rybelsus. Those in the obesity part of the study, will receive either active study drug or placebo. The study will last for about 36 weeks except for the first 25% of the participants that enter in which case the study will last for approximately 48 weeks. during this time there will be visits every 4 weeks with phone calls in between.

Preferred Primary Care Physicians (+15 Sites)Pfizer CT.gov Call CenterPfizer

25 Paid Studies Chicago Near Me

Top Cities for Paid Studies Chicago

Image of Chicago in Illinois.

Chicago

318Active Trials

Northwestern UniversityTop Active Site

Image of New York in New York.

New York

200Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site